Trillium Therapeutics to Present Clinical Data at the 62nd American Society of Hematology Annual Meeting Biotech Investing
AbbVie to Present at the Evercore ISI Conference and Piper Sandler Healthcare Conference Biotech Investing
BELLUS Health to Participate in the Evercore ISI 3rd Annual Virtual HealthCONx Conference Biotech Investing
Bristol Myers Squibb Receives European Commission Approval for Opdivo as Second-Line Treatment for Unresectable Advanced, Recurrent or Metastatic Esophageal Squamous Cell Carcinoma Biotech Investing
Gilead Sciences to Present at the 3rd Annual Evercore ISI HealthCONx Conference on Wednesday, December 2, 2020 Biotech Investing
Algernon Pharmaceuticals Announces 154 Patients Enrolled in its Multinational Phase 2b/3 Human Study of Ifenprodil for COVID-19 Biotech Investing
Amgen To Transition Development And Commercial Rights For Omecamtiv Mecarbil And AMG 594 To Cytokinetics Biotech Investing
Schrödinger Announces a Multi-Target Drug Discovery, Development, and Commercialization Collaboration with Bristol Myers Squibb Biotech Investing
HempFusion Wellness: Developing Full and Broad-Spectrum CBD Hemp Extract Production for the Consumer Markets Cannabis Investing News
